YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Ireland drugmaker rejects $46B bid from U.S. giant

Posted online
Ireland-based drugmaker Shire Pharmaceuticals has rejected a $46 billion bid from U.S. drug giant AbbVie, the firms separately confirmed in statements early Friday.

According to USA Today, the latest rejection follows two earlier bids from AbbVie that also were snubbed.

"The board believes the proposal fundamentally undervalued Shire and its prospects and that as an independent company, Shire's focused growth strategy will continue to deliver significant shareholder value and patient benefits," Shire Chairwoman Susan Kilsby said.

Read more from USA Today.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences